Psoriasis napjainkban

Translated title of the contribution: Psoriasis today

A. Szegedi, Kiss Flóra, J. Gaál

Research output: Contribution to journalArticle

Abstract

Psoriasis is one of the most common dermatological disorders. It is an immune-mediated chronic inflammatory disease that primarily affects the skin and the joints, and substantially reduces the quality of life. It occurs worldwide, with a prevalence of about 2% in developed countries. Today numerous studies are continuously published on psoriasis. Important progress has been made especially on its genetics, pathomechanism and comorbidity. In the past few years, several efficient therapeutic approaches have been developed and applied. With the appearance of biological therapies, the inflammatory process can be targeted more selectively than before. The paper reviews most recent data on the pathogenesis, immunological background, comorbidity and reduced quality of life associated with psoriasis, and presents therapeutic approaches with special focus on recent advances. The increased knowledge allows of a more efficient treatment and care of patients with proriasis, thus significantly increasing their quality of life.

Original languageHungarian
Pages (from-to)103-110
Number of pages8
JournalLege Artis Medicinae
Volume18
Issue number2
Publication statusPublished - Feb 2008

Fingerprint

Psoriasis
Quality of Life
Comorbidity
Biological Therapy
Developed Countries
Patient Care
Chronic Disease
Therapeutics
Joints
Skin

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Psoriasis napjainkban. / Szegedi, A.; Flóra, Kiss; Gaál, J.

In: Lege Artis Medicinae, Vol. 18, No. 2, 02.2008, p. 103-110.

Research output: Contribution to journalArticle

Szegedi, A, Flóra, K & Gaál, J 2008, 'Psoriasis napjainkban', Lege Artis Medicinae, vol. 18, no. 2, pp. 103-110.
Szegedi, A. ; Flóra, Kiss ; Gaál, J. / Psoriasis napjainkban. In: Lege Artis Medicinae. 2008 ; Vol. 18, No. 2. pp. 103-110.
@article{77b5a7f919684fbdafd6bcdfd49ade41,
title = "Psoriasis napjainkban",
abstract = "Psoriasis is one of the most common dermatological disorders. It is an immune-mediated chronic inflammatory disease that primarily affects the skin and the joints, and substantially reduces the quality of life. It occurs worldwide, with a prevalence of about 2{\%} in developed countries. Today numerous studies are continuously published on psoriasis. Important progress has been made especially on its genetics, pathomechanism and comorbidity. In the past few years, several efficient therapeutic approaches have been developed and applied. With the appearance of biological therapies, the inflammatory process can be targeted more selectively than before. The paper reviews most recent data on the pathogenesis, immunological background, comorbidity and reduced quality of life associated with psoriasis, and presents therapeutic approaches with special focus on recent advances. The increased knowledge allows of a more efficient treatment and care of patients with proriasis, thus significantly increasing their quality of life.",
keywords = "Comorbidity, Pathomechanism, Psoriasis, Quality of life, Therapy",
author = "A. Szegedi and Kiss Fl{\'o}ra and J. Ga{\'a}l",
year = "2008",
month = "2",
language = "Hungarian",
volume = "18",
pages = "103--110",
journal = "Lege Artis Medicinae",
issn = "0866-4811",
publisher = "Literatura Medica Publishing House",
number = "2",

}

TY - JOUR

T1 - Psoriasis napjainkban

AU - Szegedi, A.

AU - Flóra, Kiss

AU - Gaál, J.

PY - 2008/2

Y1 - 2008/2

N2 - Psoriasis is one of the most common dermatological disorders. It is an immune-mediated chronic inflammatory disease that primarily affects the skin and the joints, and substantially reduces the quality of life. It occurs worldwide, with a prevalence of about 2% in developed countries. Today numerous studies are continuously published on psoriasis. Important progress has been made especially on its genetics, pathomechanism and comorbidity. In the past few years, several efficient therapeutic approaches have been developed and applied. With the appearance of biological therapies, the inflammatory process can be targeted more selectively than before. The paper reviews most recent data on the pathogenesis, immunological background, comorbidity and reduced quality of life associated with psoriasis, and presents therapeutic approaches with special focus on recent advances. The increased knowledge allows of a more efficient treatment and care of patients with proriasis, thus significantly increasing their quality of life.

AB - Psoriasis is one of the most common dermatological disorders. It is an immune-mediated chronic inflammatory disease that primarily affects the skin and the joints, and substantially reduces the quality of life. It occurs worldwide, with a prevalence of about 2% in developed countries. Today numerous studies are continuously published on psoriasis. Important progress has been made especially on its genetics, pathomechanism and comorbidity. In the past few years, several efficient therapeutic approaches have been developed and applied. With the appearance of biological therapies, the inflammatory process can be targeted more selectively than before. The paper reviews most recent data on the pathogenesis, immunological background, comorbidity and reduced quality of life associated with psoriasis, and presents therapeutic approaches with special focus on recent advances. The increased knowledge allows of a more efficient treatment and care of patients with proriasis, thus significantly increasing their quality of life.

KW - Comorbidity

KW - Pathomechanism

KW - Psoriasis

KW - Quality of life

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=39849097013&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39849097013&partnerID=8YFLogxK

M3 - Article

VL - 18

SP - 103

EP - 110

JO - Lege Artis Medicinae

JF - Lege Artis Medicinae

SN - 0866-4811

IS - 2

ER -